PMC5775004_01
Case 1 patient's A1C over time. Arrows indicate discontinuation and recommencement of dapsone.
80fig1.jpg
PMC5775004_01_80fig1.jpg
F1
A1C was reported as 5.0 and 4.2% in June and August 2016, respectively, despite little change in his daily blood glucose monitoring levels (Figure 1). After this case, we undertook a retrospective review to look for similar cases in our clinic cohort.
PMC5775004_02
PMC5775004_03
PMC5775004_04
PMC5775004_05